Genentech : Phase III Data Show Vabysmo Improves Vision And Reduced Retinal Fluid In RVO
10/2 07:32
(RTTNews) - Genentech's vabysmo rapidly improved vision and reduced retinal fluid in people with retinal vein occlusion or RVO, as per new data from two global Phase III studies, BALATON and COMINO....